Seelos Therapeutics Inc. Stock News

On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-ti

GAINERS: Allied (OTC: ALID ) shares closed up 4.69% at $1.34 Mindset Pharma (OTC: MSSTF ) shares closed up 3.60% at $0.47 LOSERS: Seelos Therapeutics (NASDAQ: SEEL ) shares closed down 4.92% at $0.92 Mind Medicine (NASDAQ: MNMD ) shares closed down 4.76% at $1.00 Field Trip Health (NASDAQ: FTRP ) … Full story available on Benzinga.com

Seelos Therapeutics, Inc. (NASDAQ:SEEL) with the stream of -4.02% also noticed, India Solid Biosciences Inc. (NASDAQ:SLDB) encountered a rapid change of -4.61% in the last hour of Thursday’s trading session. … The post Perspiring Stock: Seelos Therapeutics, Inc. (NASDAQ:SEEL), Solid Biosciences Inc. (NASDAQ:SLDB) appeared first on Stocks Equity .

During the last session, Seelos Therapeutics Inc. (NASDAQ:SEEL)’s traded shares were 2.47 million, with the beta value of the company hitting 2.70. At the end of the trading day, the stock’s price was $1.01, reflecting an intraday gain of 8.47% or $0.08. The 52-week high for the SEEL share is $6.60, that puts it down … Is Seelos Therapeutics Inc. (NASDAQ: SEEL) Still A Buy After A -3.81% Weekly Drop? Read More »

Seelos Therapeutics (SEEL) received an acknowledgement letter of a Clinical Trial Notification ((CTN)) from the Australian Government Department of Health Therapeutic Goods…

Seelos Therapeutics Inc. (NASDAQ:SEEL) price on Thursday, March 03, rose 2.86% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.08. A look at the stock’s price movement, the close in the last trading session was $1.05, moving within a range at $1.04 and $1.11. The beta value … Seelos Therapeutics Inc. (NASDAQ: SEEL): A Sinfully Good Stock To Watch Read More »

GAINERS: Seelos Therapeutics (NASDAQ: Full story available on Benzinga.com

GAINERS: Seelos Therapeutics (NASDAQ: SEEL ) shares closed up 11.06% at $1.10 Mind Medicine (NASDAQ: MNMD ) shares closed up 11.01% at $1.21 Compass Pathways (NASDAQ: CMPS ) shares closed up 4.50% at $13.23 ATAI Life Sciences (NASDAQ: ATAI ) shares closed up 3.83% at $5.42 Mindset Pharma (OTC: Full story available on Benzinga.com

GAINERS: Small Pharma (OTC: Full story available on Benzinga.com

GAINERS: Small Pharma (OTC: DMTTF ) shares closed up 14.55% at $0.21 GH Research (NASDAQ: GHRS ) shares closed up 3.35% at $16.99 Field Trip Health (NASDAQ: FTRP ) shares closed up 2.00% at $2.04 LOSERS: Mindset Pharma (OTC: MSSTF ) shares closed down -4.33% at $0.57 Seelos Therapeutics (NASDAQ: SEEL ) shares closed down Full story available on Benzinga.com

Brokerages forecast that Seelos Therapeutics, Inc. (NASDAQ:SEEL) will report earnings per share of ($0.12) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Seelos Therapeutics earnings. The highest EPS estimate is ($0.11) and the lowest is ($0.12). Seelos Therapeutics posted earnings per share of ($0.13) during the same []

Seelos received communication from the FDA that its part 2 study will be considered registrational. This derisks the company considerably, although the only efficacy data we have so far is from an ope

NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has granted